Kalkine has a fully transformed New Avatar.

small-cap

One Stock in the Health Supplement Space to Accumulate at Current Levels - BKL

Jun 17, 2022 | Team Kalkine
One Stock in the Health Supplement Space to Accumulate at Current Levels - BKL

 

Blackmores Limited

1Ratios such as P/E, EPS, ADY are on Trailing Twelve-Month basis, which are subject to change based on certain factors such as company performance, and stock price changes.

2ROE has been taken for the Half-Year Ending December 2021.

BKL Details

This report is an updated version of the report published on 17 June 2022 at ~3:52 PM GMT

Blackmores Limited (ASX: BKL) is engaged in manufacturing ad supplying vitamin, herbal, mineral supplements and natural skin and hair treatment products in Australia and New Zealand. On 15 June 2022, the company announced that an Independent Non-Executive Director, David Ansell, has provided BKL with notice of his resignation effective Thursday, 30 June 2022.

H1FY22 Financial Highlights:

  • Increased Top-Line: Sales revenue increased by 14.3%, owing to distribution expansion and robust execution of product innovation directing to market share gains, especially in the International and China segments.
  • Bottom-Line Highlights: Aligned with revenue performance, BKL continued to deliver improved gross profit and EBIT margin expansion during H1FY22. The bottom line expanded due to opex savings, supply chain efficiencies, and targeted price/mix initiatives.

Underlying Operating Metrics; Analysis by Kalkine Group

Key Risks and Challenges

The company would require disciplined cost management and investment flow due to macro risks, such as supply chain constraints and changing consumer behaviour.

Outlook

BKL expects a recovery in the Australian market with a focus on reducing out of stocks and accelerating the delivery of new product innovation. Favourable performance of the international markets will sustain longer with momentum from new product launches. Total group A&P investments are estimated to clock $10 to $15 million higher in H1FY22 relative to H1FY21.

Valuation Methodology: EV/Sales Multiple Based Relative Valuation (Illustrative)

Source: Analysis by Kalkine Group

*% Premium/(Discount) is based on our assessment of the company’s NTM trading multiple after considering its key growth drivers, economic moat, stock’s historical trading multiples versus peer average/median, and investment risks.

Stock Recommendation: The stock of BKL gave a negative return of ~21.07% in the past six months. The stock is currently trading lower than the 52-week average price level band of $67.500 - $103.970. The stock has been valued using the EV/Sales multiple-based illustrative relative valuation method and arrived at a target price with an upside of low double-digit (in percentage terms). Considering the potential supply chain constraints and potential policy concerns from the Chinese market, the company might trade at a slight discount to its peers’ EV/Sales multiple average. For valuation, a few peers like McPherson’s Ltd (ASX: MCP), BWX Ltd (ASX: BWX), Biome Australia Ltd (ASX: BIO) and others have been considered. Given the favourable top-line stance, cost-saving measures, controlled inventory management, current trading levels, and upside indicated by valuation, we give a “Buy” recommendation on the stock at the current market price of $68.490, as of 17 June 2022, at 10:40 AM (GMT+10), Sydney, Eastern Australia.

Markets are currently trading in a highly volatile zone due to prevailing macroeconomic and geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

BKL Daily Technical Chart, Data Source: REFINITIV

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Note 2: Investment decisions should be made depending on the investors’ appetite for upside potential, risks, holding duration, and previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the Valuation has been achieved and is subject to the factors discussed above.

Technical Indicators Defined: -

Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.

Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.


Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.